OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
27
Results
Show all
Save search
Copy query
Show results for
Unknown
(27)
Publication Date
Release Date
2021
(10)
2022
(7)
2023
(3)
2025
(2)
2024
(2)
2020
(1)
2015
(1)
2014
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Internal Illumination to Overcome the Cell Density Limitation in the Scale-up of Whole-Cell Photobiocatalysis.
Not available
S-EPMC8456840
|
biostudies-literature
Cite
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.
Not available
S-EPMC4146673
|
biostudies-literature
Cite
NeuroX, a fast and efficient genotyping platform for investigation of neurodegenerative diseases.
Not available
S-EPMC4317375
|
biostudies-literature
Cite
Sub-genic intolerance, ClinVar, and the epilepsies: A whole-exome sequencing study of 29,165 individuals.
Not available
S-EPMC8206159
|
biostudies-literature
Cite
Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
Not available
S-EPMC8491132
|
biostudies-literature
Cite
Genome-wide identification and phenotypic characterization of seizure-associated copy number variations in 741,075 individuals.
Not available
S-EPMC10359300
|
biostudies-literature
Cite
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
Not available
S-EPMC8121538
|
biostudies-literature
Cite
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355
|
biostudies-literature
Cite
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998
|
biostudies-literature
Cite
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8830904
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets